Suppr超能文献

郝氏食管胃造瘘术(HEFT)在近端胃切除术中的应用:一项前瞻性、多中心、随机对照研究方案

Application of Hao's Esophagogastrostomy by Fissure Technique (HEFT) in proximal gastrectomy: protocol for a prospective, multicentre, randomised controlled study.

作者信息

Cui Wen-Liang, Wang Ze-Qin, Shi Xue-Liang, Ma Ming-Ye, Wang Jian, Wang Zi-Hao, Wang Ya-Ping, Hong Jun, Hao Han-Kun

机构信息

Division of Gastrointestinal Surgery, Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.

Division of Gastrointestinal Surgery, Qidong People's Hospital, Qidong, Jiangsu, China.

出版信息

BMJ Open. 2025 Aug 12;15(8):e104365. doi: 10.1136/bmjopen-2025-104365.

Abstract

BACKGROUND

Proximal gastrectomy (PG) has emerged as the preferred surgical approach for adenocarcinoma of the upper 1/3 stomach and selected cases of oesophagogastric junction adenocarcinoma. We developed a novel oesophagogastric anastomosis technique with an antireflux mechanism (Hao's Esophagogastrostomy by Fissure Technique). It may have a superior effect on patient weight maintenance compared with the double-tract reconstruction. We intend to conduct a prospective, multicentre, randomised controlled clinical trial to validate this hypothesis.

METHODS AND ANALYSIS

The primary objective evaluates body weight loss at 12 months postoperatively. Secondary objectives assess surgical safety through comprehensive analysis of complication rates and nutritional parameters, including serial haematological evaluations during follow-up. The study will enrol 52 participants across multiple centres with planned 3-year longitudinal monitoring to evaluate both immediate postoperative outcomes and intermediate-term clinical impacts.

ETHICS AND DISSEMINATION

This study was approved by the hospital institutional review board of Huashan Hospital, Fudan University (2024-1173) and is being conducted in accordance with the Declaration of Helsinki and the Good Clinical Practice guidelines. On completion of the study, the results will be published in a peer-reviewed journal.

TRIAL REGISTRATION NUMBER

NCT06679244.

摘要

背景

近端胃切除术(PG)已成为治疗胃上1/3腺癌和部分食管胃交界腺癌的首选手术方式。我们开发了一种具有抗反流机制的新型食管胃吻合技术(郝氏裂沟法食管胃吻合术)。与双通道重建相比,它可能对患者体重维持有更好的效果。我们打算进行一项前瞻性、多中心、随机对照临床试验来验证这一假设。

方法与分析

主要目标是评估术后12个月时的体重减轻情况。次要目标是通过综合分析并发症发生率和营养参数(包括随访期间的系列血液学评估)来评估手术安全性。该研究将在多个中心招募52名参与者,计划进行3年的纵向监测,以评估术后即时结果和中期临床影响。

伦理与传播

本研究已获得复旦大学附属华山医院医院伦理委员会批准(2024 - 1173),并按照《赫尔辛基宣言》和《药物临床试验质量管理规范》指南进行。研究完成后,结果将发表在同行评审期刊上。

试验注册号

NCT06679244。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f75b/12352199/b515c3183670/bmjopen-15-8-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验